Clinical Trials Directory

Trials / Completed

CompletedNCT03580954

Transcranial Magnetic Stimulation in Primary Progressive Aphasia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Hospital San Carlos, Madrid · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

Primary progressive aphasia (PPA) is a clinical syndrome characterized by the neurodegeneration of language brain systems. Three main clinical variants are currently recorgnized (nonfluent, semantic, and logopenic PPA). Nowadays, there are no effective treatments for this disorder. Transcranial Magnetic Stimulation (TMS) is a technique based on the principle of electromagnetic induction of an electric field in the brain. It has been used as a non-invasive therapy in different disorders, such as depression, bipolar disorder, Parkinson's disease, and in the rehabilitation of post-stroke aphasia. Recent studies have shown how repetitive TMS improved language characteristics in Alzheimer's disease, and there are initial data in patients with PPA. This research project investigates the effect of repetitive TMS in patients with PPA. Investigators will perform a personalized TMS treatment for each patient (brain region, type of stimulation/inhibition, etc.), according to the specific characteristics of each patient and with the final aim to generate a computational model.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Magnetic StimulationStimulation or inhibition using TMS will be delivered guided by a neuronavigator system in different brain regions.

Timeline

Start date
2018-02-01
Primary completion
2020-03-10
Completion
2020-03-10
First posted
2018-07-10
Last updated
2020-05-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03580954. Inclusion in this directory is not an endorsement.

Transcranial Magnetic Stimulation in Primary Progressive Aphasia (NCT03580954) · Clinical Trials Directory